Literature DB >> 26455685

Using mechanism of action to choose medications for treatment-resistant depression.

Michael E Thase1, Thomas L Schwartz.   

Abstract

Remission rates for depression continue to be low, and for many patients, complex treatment regimens are needed for optimal response. Many physicians do not fully understand how and why depression medications work or which ones will complement each other. This CME Webcast covers the different mechanisms of action of current pharmacotherapeutic options for depression, both monotherapy and adjunctive medications, and shows clinicians how to use their understanding of mechanisms of action to choose the most effective treatment strategy for their patients, especially those with treatment-resistant or difficult-to-treat depression. © Copyright 2015 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26455685     DOI: 10.4088/JCP.14052wc1c

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  2 in total

1.  Deep Brain Stimulation for Depression.

Authors:  Martijn Figee; Patricio Riva-Posse; Ki Sueng Choi; Lucia Bederson; Helen S Mayberg; Brian H Kopell
Journal:  Neurotherapeutics       Date:  2022-07-11       Impact factor: 6.088

2.  Adjunctive vortioxetine for SSRI-resistant major depressive disorder: a "real-world" chart review study.

Authors:  Domenico De Berardis; Michele Fornaro; Annalisa Anastasia; Federica Vellante; Luigi Olivieri; Gabriella Rapini; Nicola Serroni; Laura Orsolini; Alessandro Valchera; Alessandro Carano; Carmine Tomasetti; Antonio Ventriglio; Massimiliano Bustini; Maurizio Pompili; Gianluca Serafini; Giampaolo Perna; Felice Iasevoli; Giovanni Martinotti; Massimo Di Giannantonio
Journal:  Braz J Psychiatry       Date:  2020-03-09       Impact factor: 2.697

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.